Tigran V. Yuzbashev

Tigran V. Yuzbashev

Auto-generated profile, based on publicly available information

Tigran V. Yuzbashev

Rothamsted Research

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2010 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
PDF file
TYTigran V. Yuzbashev
Tigran V. Yuzbashev
EYEvgeniya Y. Yuzbasheva
Evgeniya Y. Yuzbasheva
TSTatiana I. Sobolevskaya
Tatiana I. Sobolevskaya
ILIvan A. Laptev
Ivan A. Laptev
TVTatiana Vybornaya
Tatiana Vybornaya
SSSergey P. Sineoky
Sergey P. Sineoky

15 April 2011 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
EYEvgeniya Yu Yuzbasheva
Evgeniya Yu Yuzbasheva
TYTigran V. Yuzbashev
Tigran V. Yuzbashev
ILIvan A. Laptev
Ivan A. Laptev
TKTatiana K. Konstantinova
Tatiana K. Konstantinova
SSSergey P. Sineoky
Sergey P. Sineoky

15 March 2015 in Applied Biochemistry and Biotechnology
Verified
Journal Article
Closed access
PDF file
EYEvgeniya Yu Yuzbasheva
Evgeniya Yu Yuzbasheva
TYTigran V. Yuzbashev
Tigran V. Yuzbashev
NPNatalia I. Perkovskaya
Natalia I. Perkovskaya
EMElizaveta B. Mostova
Elizaveta B. Mostova
TVTatiana Vybornaya
Tatiana Vybornaya
SSSergey P. Sineoky
Sergey P. Sineoky

1 October 2017 in New Biotechnology
Verified
Journal Article
Closed access
EYEvgeniya Yu Yuzbasheva
Evgeniya Yu Yuzbasheva
EMElizaveta B. Mostova
Elizaveta B. Mostova
NANatalia I. Andreeva
Natalia I. Andreeva
TYTigran V. Yuzbashev
Tigran V. Yuzbashev
ILIvan A. Laptev
Ivan A. Laptev
SSSergey P. Sineoky
Sergey P. Sineoky

18 August 2023 in Communications Biology
Verified
Journal Article
Open access
PDF file
TYTigran V. Yuzbashev
Tigran V. Yuzbashev
EYEvgeniya Yu Yuzbasheva
Evgeniya Yu Yuzbasheva
OMOlga Melkina
Olga Melkina
DPDavina Patel
Davina Patel
DBDmitrii Bubnov
Dmitrii Bubnov
Rodrigo Ledesma-AmaroRodrigo Ledesma-Amaro
Rodrigo Ledesma-Amaro
CRISPR/Cas9-based technologies are revolutionising the way we engineer microbial cells. One of the key advantages of CRISPR in strain design is that it enables chromosomal integration of marker-free DNA, eliminating laborious and often inefficient marker recovery procedures. Despite the benefits, assembling CRISPR/Cas9 editing systems is still not a straightforward process, which may prevent its use and applications. In this work, we have identified some of the main limitations of current Cas9 toolkits and designed improvements with the goal of making CRISPR technologies easier to access and implement. These include 1) A system to quickly switch between marker-free and marker-based integration constructs using both a Cre-expressing and standard Escherichia coli strains, 2) the ability to redirect multigene integration cassettes into alternative genomic loci via Golden Gate-based exchange of homology arms, 3) a rapid, simple in-vivo method to assembly guide RNA sequences via recombineering between Cas9-helper plasmids and single oligonucleotides. We combine these methodologies with well-established technologies into a comprehensive toolkit for efficient metabolic engineering using CRISPR/Cas9. As a proof of concept, we developed the YaliCraft toolkit for Yarrowia lipolytica, which is composed of a basic set of 147 plasmids and 7 modules with different purposes. We used the toolkit to generate and characterize a library of 137 promoters and to build a de novo strain synthetizing 373.8 mg/L homogentisic acid.

1 March 2011 in Bioengineered Bugs
Verified
Journal Article
Closed access
PDF file
TYTigran V. Yuzbashev
Tigran V. Yuzbashev
EYEvgeniya Y. Yuzbasheva
Evgeniya Y. Yuzbasheva
ILIvan A. Laptev
Ivan A. Laptev
TSTatiana I. Sobolevskaya
Tatiana I. Sobolevskaya
TVTatiana Vybornaya
Tatiana Vybornaya
SSSergey P. Sineoky
Sergey P. Sineoky
Bio-based succinate is still a matter of special emphasis in biotechnology and adjacent research areas. The vast majority of natural and engineered producers are bacterial strains that accumulate succinate under anaerobic conditions. Recently, we succeeded in obtaining an aerobic yeast strain capable of producing succinic acid at low pH. Herein, we discuss some difficulties and advantages of microbial pathways producing “succinic acid” rather than “succinate”. It was concluded that the peculiar properties of the constructed yeast strain could be clarified in view of a distorted energy balance. There is evidence that in an acidic environment, the majority of the cellular energy available as ATP will be spent for proton and anion efflux. The decreased ATP:ADP ratio could essentially reduce the growth rate or even completely inhibit growth. In the same way, the preference of this elaborated strain for certain carbon sources could be explained in terms of energy balance. Nevertheless, the opportunity to exclude alkali and mineral acid waste from microbial succinate production seems environmentally friendly and cost-effective.